Literature DB >> 21940944

Pericyte-derived sphingosine 1-phosphate induces the expression of adhesion proteins and modulates the retinal endothelial cell barrier.

Paul G McGuire1, Sampathkumar Rangasamy, Joann Maestas, Arup Das.   

Abstract

OBJECTIVE: The mechanisms that regulate the physical interaction of pericytes and endothelial cells and the effects of these interactions on interendothelial cell junctions are not well understood. We determined the extent to which vascular pericytes could regulate pericyte-endothelial adhesion and the consequences that this disruption might have on the function of the endothelial barrier. METHODS AND
RESULTS: Human retinal microvascular endothelial cells were cocultured with pericytes, and the effect on the monolayer resistance of endothelial cells and expression of the cell junction molecules N-cadherin and VE-cadherin were measured. The molecules responsible for the effect of pericytes or pericyte-conditioned media on the endothelial resistance and cell junction molecules were further analyzed. Our results indicate that pericytes increase the barrier properties of endothelial cell monolayers. This barrier function is maintained through the secretion of pericyte-derived sphingosine 1-phosphate. Sphingosine 1-phosphate aids in maintenance of microvascular stability by upregulating the expression of N-cadherin and VE-cadherin, and downregulating the expression of angiopoietin 2.
CONCLUSIONS: Under normal circumstances, the retinal vascular pericytes maintain pericyte-endothelial contacts and vascular barrier function through the secretion of sphingosine 1-phosphate. Alteration of pericyte-derived sphingosine 1-phosphate production may be an important mechanism in the development of diseases characterized by vascular dysfunction and increased permeability.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21940944      PMCID: PMC3225006          DOI: 10.1161/ATVBAHA.111.235408

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  63 in total

1.  Angiopoietin-2, a natural antagonist for Tie2 that disrupts in vivo angiogenesis.

Authors:  P C Maisonpierre; C Suri; P F Jones; S Bartunkova; S J Wiegand; C Radziejewski; D Compton; J McClain; T H Aldrich; N Papadopoulos; T J Daly; S Davis; T N Sato; G D Yancopoulos
Journal:  Science       Date:  1997-07-04       Impact factor: 47.728

2.  Mechanotransduction across the cell surface and through the cytoskeleton.

Authors:  N Wang; J P Butler; D E Ingber
Journal:  Science       Date:  1993-05-21       Impact factor: 47.728

3.  Advanced glycation end products (AGEs) co-localize with AGE receptors in the retinal vasculature of diabetic and of AGE-infused rats.

Authors:  A W Stitt; Y M Li; T A Gardiner; R Bucala; D B Archer; H Vlassara
Journal:  Am J Pathol       Date:  1997-02       Impact factor: 4.307

Review 4.  Pericytes in the microvasculature.

Authors:  K K Hirschi; P A D'Amore
Journal:  Cardiovasc Res       Date:  1996-10       Impact factor: 10.787

5.  Pericyte loss and microaneurysm formation in PDGF-B-deficient mice.

Authors:  P Lindahl; B R Johansson; P Levéen; C Betsholtz
Journal:  Science       Date:  1997-07-11       Impact factor: 47.728

Review 6.  Diabetic macular edema: pathogenesis and treatment.

Authors:  Neelakshi Bhagat; Ruben A Grigorian; Arthur Tutela; Marco A Zarbin
Journal:  Surv Ophthalmol       Date:  2009 Jan-Feb       Impact factor: 6.048

7.  Pericyte coverage of retinal and cerebral capillaries.

Authors:  R N Frank; T J Turczyn; A Das
Journal:  Invest Ophthalmol Vis Sci       Date:  1990-06       Impact factor: 4.799

8.  ATP causes retinal pericytes to contract in vitro.

Authors:  A Das; R N Frank; M L Weber; A Kennedy; C A Reidy; M A Mancini
Journal:  Exp Eye Res       Date:  1988-03       Impact factor: 3.467

9.  PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate.

Authors:  K K Hirschi; S A Rohovsky; P A D'Amore
Journal:  J Cell Biol       Date:  1998-05-04       Impact factor: 10.539

10.  Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B.

Authors:  C Rosette; M Karin
Journal:  J Cell Biol       Date:  1995-03       Impact factor: 10.539

View more
  27 in total

1.  Role of bone marrow-derived cells in angiogenesis: focus on macrophages and pericytes.

Authors:  Yanping Ding; Nan Song; Yongzhang Luo
Journal:  Cancer Microenviron       Date:  2012-04-20

Review 2.  Recent molecular discoveries in angiogenesis and antiangiogenic therapies in cancer.

Authors:  Jonathan Welti; Sonja Loges; Stefanie Dimmeler; Peter Carmeliet
Journal:  J Clin Invest       Date:  2013-08-01       Impact factor: 14.808

3.  Sphingosine 1-phosphate receptors are essential mediators of eyelid closure during embryonic development.

Authors:  Deron R Herr; Chang-Wook Lee; Wei Wang; Adam Ware; Richard Rivera; Jerold Chun
Journal:  J Biol Chem       Date:  2013-09-03       Impact factor: 5.157

4.  Pericyte chemomechanics and the angiogenic switch: insights into the pathogenesis of proliferative diabetic retinopathy?

Authors:  Jennifer T Durham; Brian M Dulmovits; Stephen M Cronk; Anthony R Sheets; Ira M Herman
Journal:  Invest Ophthalmol Vis Sci       Date:  2015-06       Impact factor: 4.799

5.  Mrp1 is essential for sphingolipid signaling to p-glycoprotein in mouse blood-brain and blood-spinal cord barriers.

Authors:  Tara A Cartwright; Christopher R Campos; Ronald E Cannon; David S Miller
Journal:  J Cereb Blood Flow Metab       Date:  2012-11-21       Impact factor: 6.200

Review 6.  Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges.

Authors:  Dai Fukumura; Jonas Kloepper; Zohreh Amoozgar; Dan G Duda; Rakesh K Jain
Journal:  Nat Rev Clin Oncol       Date:  2018-03-06       Impact factor: 66.675

7.  Pericytes on the tumor vasculature: jekyll or hyde?

Authors:  Keith D Barlow; Anne M Sanders; Shay Soker; Suleyman Ergun; Linda J Metheny-Barlow
Journal:  Cancer Microenviron       Date:  2012-03-31

Review 8.  Sphingolipids in spinal cord injury.

Authors:  Zachary B Jones; Yi Ren
Journal:  Int J Physiol Pathophysiol Pharmacol       Date:  2016-08-05

9.  Therapeutic regulation of VE-cadherin with a novel oligonucleotide drug for diabetic eye complications using retinopathy mouse models.

Authors:  Ka Ka Ting; Yang Zhao; Weiyong Shen; Paul Coleman; Michelle Yam; Tailoi Chan-Ling; Jia Li; Thorleif Moller; Mark Gillies; Mathew A Vadas; Jennifer R Gamble
Journal:  Diabetologia       Date:  2018-11-15       Impact factor: 10.122

10.  Establishment and characterization of an embryonic pericyte cell line.

Authors:  Huaning Zhao; Jordan Darden; John C Chappell
Journal:  Microcirculation       Date:  2018-06-07       Impact factor: 2.628

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.